Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Olson

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|September 17, 2004
The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanismDenis O'Keeffe, Steven T Olson, Nijole Gasiunas, et al.
Cancer Research|May 19, 2006
Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cellsWeiqing Zhang, Yung-Jen Chuang, Tianquan Jin, et al.
The Journal of Biological Chemistry|December 5, 2006
Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1Richard Swanson, Manikanahally P Raghavendra, Weiqing Zhang, et al.
The Journal of Biological Chemistry|September 12, 2015
Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated StatesRyan Roth, Richard Swanson, Gonzalo Izaguirre, et al.
Blood|July 13, 2012
Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein ZXin Huang, Yahui Yan, Yizheng Tu, et al.
Protein Science : a Publication of the Protein Society|January 6, 2005
Specificity and reactive loop length requirements for crmA inhibition of serine proteasesLisa D Tesch, Manikanahally P Raghavendra, Tina Bedsted-Faarvang, et al.
The Journal of Biological Chemistry|September 27, 2013
The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix DAlexey Dementiev, Richard Swanson, Ryan Roth, et al.
The Journal of Biological Chemistry|February 20, 2003
Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosisSrikumar M Raja, Neetu Chhablani, Richard Swanson, et al.
Biochemistry|April 10, 2002
Importance of lysine 125 for heparin binding and activation of antithrombinSophia Schedin-Weiss, Umesh R Desai, Susan C Bock, et al.
The Journal of Biological Chemistry|April 1, 2008
Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombinBenjamin Richard, Richard Swanson, Sophia Schedin-Weiss, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|September 17, 2004
The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanismDenis O'Keeffe, Steven T Olson, Nijole Gasiunas, et al.
Cancer Research|May 19, 2006
Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cellsWeiqing Zhang, Yung-Jen Chuang, Tianquan Jin, et al.
The Journal of Biological Chemistry|December 5, 2006
Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1Richard Swanson, Manikanahally P Raghavendra, Weiqing Zhang, et al.
The Journal of Biological Chemistry|September 12, 2015
Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated StatesRyan Roth, Richard Swanson, Gonzalo Izaguirre, et al.
Blood|July 13, 2012
Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein ZXin Huang, Yahui Yan, Yizheng Tu, et al.
Protein Science : a Publication of the Protein Society|January 6, 2005
Specificity and reactive loop length requirements for crmA inhibition of serine proteasesLisa D Tesch, Manikanahally P Raghavendra, Tina Bedsted-Faarvang, et al.
The Journal of Biological Chemistry|September 27, 2013
The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix DAlexey Dementiev, Richard Swanson, Ryan Roth, et al.
The Journal of Biological Chemistry|February 20, 2003
Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosisSrikumar M Raja, Neetu Chhablani, Richard Swanson, et al.
Biochemistry|April 10, 2002
Importance of lysine 125 for heparin binding and activation of antithrombinSophia Schedin-Weiss, Umesh R Desai, Susan C Bock, et al.
The Journal of Biological Chemistry|April 1, 2008
Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombinBenjamin Richard, Richard Swanson, Sophia Schedin-Weiss, et al.
Pageof 7